文献速递多重用药衰弱、肌少症与跌倒老年慢病共病管理

优化老年患者用药管理的干预措施:系统综述的伞状综述

Interventions to Optimize Medication Management in Older Adults: An Umbrella Review of Systematic Reviews.
PubMed 文献 · J Am Geriatr Soc · 2026-06-24

药师主导的用药审查和多学科药物审查在改善用药适宜性、减少跌倒和计划外医疗使用方面效果最一致,但整体证据强度受方法学异质性限制。

要点

  • 药师主导审查和多学科审查最一致地改善用药适宜性并减少跌倒。
  • 教育、政策和社区干预对依从性或处方质量效果混合或有限。
  • 纳入系统综述方法学质量不一,多为中至高偏倚风险。

核心结论

  • 药师主导和多学科药物审查显示最一致的获益,改善用药适宜性并减少跌倒和计划外医疗使用。
  • 教育、政策与指南措施及社区策略效果混合或有限,常限于依从性或处方质量。
  • 整体证据强度受方法学异质性限制,需高质量、情境特异性研究。

研究设计与样本

  • 伞状综述,系统检索PubMed、Embase、Scopus、Web of Science和Cochrane CENTRAL至2024年。
  • 使用AMSTAR-2工具评估方法学质量,采用描述性统计并判定证据可信度。

主要发现

  • 药师主导审查和减处方干预均显示用药适宜性显著改善。
  • 多学科方法和临床决策支持系统可改善依从性和处方实践。
  • 生活质量、认知功能和死亡率等临床结局改善不一致。
  • 经济学评价结果混合。
  • 在减少药物数量、不适当处方和跌倒方面证据令人信服。

关键数值与推荐

  • 纳入系统综述聚焦药师主导审查、减处方方案、教育项目、临床决策支持系统和社区干预。
  • AMSTAR-2评估显示纳入系统综述方法学质量不一,许多为中至高偏倚风险。

临床怎么用

  • 优先采用药师主导或多学科药物审查以改善用药适宜性并减少跌倒。
  • 对教育、政策和社区干预的效果保持审慎,其获益常限于依从性或处方质量。
  • 实施时需考虑可扩展性和资源分配等挑战。

局限性

  • 纳入系统综述方法学质量不一,多为中至高偏倚风险。
  • 整体证据强度受方法学异质性限制。
  • 需要高质量、情境特异性且结局标准化的未来研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Medication management in older adults with multimorbidity and polypharmacy is inherently challenging. This umbrella review consolidates evidence on interventions aimed at mitigating these challenges to promote safe and effective medication use. METHODS: This was an umbrella review. A systematic search was conducted on PubMed, Embase, Scopus, Web of Science, and Cochrane CENTRAL until 2024 to find relevant systematic reviews of interventions to improve medication management among older adults aged ≥ 60 years (PROSPERO ID: CRD42024607956). Eligible systematic reviews focused on pharmacist-led reviews, deprescribing protocols, educational programs, clinical decision support systems (CDSS), and community-based initiatives. Data were extracted, and methodological quality was evaluated using the AMSTAR-2 tool. Descriptive statistics were applied, and the credibility of the evidence was determined. Outcomes included medication optimization, clinical, healthcare utilization and cost, and acceptability of the intervention among physicians and patients. RESULTS: Seventy-one systematic reviews with > 1.5 million cumulative participants were included. According to the AMSTAR-2 assessment, the included systematic reviews demonstrated variable methodological quality, with many rated as moderate to high risk of bias. Pharmacist-led reviews and deprescribing interventions both indicated significant improvement in medication appropriateness. Multidisciplinary approaches and CDSS could improve adherence and prescribing practices. Improvements in clinical outcomes, such as quality of life, cognitive function, and mortality, were inconsistent. Economic evaluations showed mixed results. Implementation challenges were identified, including scalability and resource allocation. Evidence was convincing in reducing the number of medications, inappropriate prescribing, and falls. CONCLUSIONS: Pharmacist-led and multidisciplinary medication reviews showed the most consistent benefits, improving medication appropriateness and reducing falls and unplanned healthcare use. Interventions like education, policy and guideline measures, and community-based strategies demonstrated mixed or modest effects, often limited to adherence or prescribing quality. Overall evidence strength was limited by methodological heterogeneity. Future high-quality, context-specific research with standardized outcomes is needed in this regard.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Das S, Shukla S, Aadityan R, et al. Interventions to Optimize Medication Management in Older Adults: An Umbrella Review of Systematic Reviews. J Am Geriatr Soc. 2026. PMID: 42339921. doi:10.1111/jgs.70561

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。